Tag: pharmaceuticals
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Aurinia Pharmaceuticals Inc. Inve… –...
NEW YORK, April 30, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of...
INVESTOR ALERT: Aurinia Pharmaceuticals Inc. Investors with Substantial Losses H… –...
SAN DIEGO, April 23, 2022 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of...
DEADLINE: Aurinia Pharmaceuticals Inc. Investors with Substantial Losses Have Op… –...
The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Aurinia Pharmaceuticals Inc. AUPH securities between May...
Rhizen Pharmaceuticals AG Presents Data on Its Differentiated PARP and DHODH...
Rhizen Pharma announces presentations at AACR showcasing its differentiated clinical stage PARP and DHODH programs
Preclinical data on Rhizen's differentiated PARP inhibitor RP12146, indicates...
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Fennec Pharmaceuticals Inc. Investors… – Press...
NEW YORK, April 02, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of...
MONDAY DEADLINE: NRx Pharmaceuticals, Inc. Investors with Significant Losses Hav… –...
SAN DIEGO, March 17, 2022 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of NRx Pharmaceuticals, Inc. NRXP...
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages NRx Pharmaceuticals, Inc. Investo… – Press...
NEW YORK, March 13, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of...